Calendar Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq 21:00:00 17/06/2024 BST 5-day change 1st Jan Change
6.35 USD +1.76% Intraday chart for Vanda Pharmaceuticals Inc. +6.19% +50.47%

Chart calendar Vanda Pharmaceuticals Inc.

84f3bd797a43074a8d17ff4abd3e322.3sXoP28Jyd8rKHXGnu9gjLOS-XkmxF0OeZ3PTi6ANIo.6YfRcDh6rJ1gBU2Uzq1Y9YrrsxJn8TVtPM-qCh3EZbuOk5l6OzmjmB9hHg~2ffe898de3074d8bfe2a5ad277151dbd

Upcoming events on Vanda Pharmaceuticals Inc.

30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
04/02/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Vanda Pharmaceuticals Inc.

06/06/2024 19:00 Jefferies Global Healthcare Conference
17/05/2024 14:00 Annual General Meeting
08/05/2024 21:30 Q1 2024 Earnings Call
08/05/2024 21:01 Q1 2024 Earnings Release
07/02/2024 21:30 Q4 2023 Earnings Call
07/02/2024 21:02 Q4 2023 Earnings Release
09/01/2024 17:45 JPMorgan Healthcare Conference
16/11/2023 14:00 Jefferies London Healthcare Conference
14/11/2023 21:10 Stifel Healthcare Conference
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:01 Q3 2023 Earnings Release
11/10/2023 18:25 Jefferies Inaugural Biotech CNS/Neuro Summit
13/09/2023 21:00 H.C. Wainwright Global Investment Conference
27/07/2023 21:30 Q2 2023 Earnings Call
26/07/2023 Q2 2023 Earnings Release After hours
09/06/2023 17:15 Jefferies Global Healthcare Conference
08/06/2023 14:00 Annual General Meeting
03/05/2023 21:30 Q1 2023 Earnings Call
03/05/2023 21:01 Q1 2023 Earnings Release
08/02/2023 21:30 FY 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
227
226
0.61%
248
245
1.5%
269
271
-0.75%
254
258
-1.21%
193
184
4.47%

195

EBITDA
Million USD
Released
Forecast
Spread
39,2
27,8
40.86%
0,00
0,00
-
45,0
45,5
-1.04%
0,00
0,00
-
0,00
0,00
-

-20,2

EBIT
Million USD
Released
Forecast
Spread
22,8
32,3
-29.38%
27,2
24,2
12.56%
42,2
40,4
4.45%
6,33
5,50
15.07%
-14,0
-18,4
24.17%

-21,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
29,0
33,9
-14.37%
31,7
25,9
22.22%
42,4
40,3
5.12%
11,3
6,20
82.26%
6,34
2,60
143.81%

-1,90

Net income
Million USD
Released
Forecast
Spread
116
121
-4.74%
23,3
24,1
-3.17%
33,2
31,1
6.58%
6,28
2,70
132.41%
2,51
-0,50
601.8%

-3,60

EPS
USD
Released
Forecast
Spread
2,11
2,17
-2.76%
0,42
0,46
-7.74%
0,58
0,54
8.41%
0,11
0,04
175%
0,04
-0,01
500%

-0,06

Announcement Date25/02/2010/02/2123/02/2208/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
60,2
58,0
3.78%
64,4
67,0
-3.9%
65,3
71,0
-8%
64,5
67,6
-4.61%
46,1
49,0
-6.01%
38,8
44,5
-12.78%
45,3
37,0
22.35%
EBIT
Million USD
Released
Forecast
Spread
-7,67
-0,60
-1178.17%
3,46
9,70
-64.32%
3,91
6,60
-40.79%
6,63
5,80
14.29%
-2,87
-9,40
69.5%
-6,00
-2,60
-130.58%
-7,09
-11,5
38.31%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,56
-0,60
-1160.67%
3,79
9,70
-60.93%
5,46
6,90
-20.86%
9,61
6,10
57.59%
2,59
-9,40
127.57%
-0,12
-2,60
95.38%
-1,66
-5,40
69.24%
Net income
Million USD
Released
Forecast
Spread
-6,43
-0,50
-1186%
2,57
7,70
-66.57%
3,27
5,40
-39.44%
6,86
4,80
42.94%
1,52
-7,50
120.27%
0,14
-2,60
105.27%
-2,40
-5,40
55.56%
EPS
USD
Released
Forecast
Spread
-0,11
-0,01
-1000%
0,05
0,12
-58.33%
0,06
0,09
-33.33%
0,12
0,08
50%
0,03
-0,13
123.08%
0,00
-0,04
-
-0,04
-0,09
55.56%
Announcement Date05/05/2203/08/2202/11/2208/02/2327/07/2308/11/2307/02/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. Calendar Vanda Pharmaceuticals Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW